NLRC4 Methylation and Its Response to Intravenous Immunoglobulin Therapy in Kawasaki Disease: a Case Control Study

Overview

Journal BMC Pediatr

Publisher Biomed Central

Specialty Pediatrics

Date 2024 Mar 17

PMID 38493129

Authors

Beirong Yu

Bangxu Zheng

Yu Shen

Yijing Shen

Haiyan Qiu

Ling Wu

Yuanling Chen

Xiaohong Cai

Junhua Wu

Qingxiao Hong

Affiliations

Soon will be listed here.

Abstract

Background: Kawasaki disease (KD) is a systemic vasculitis accompanied by many systemic physiological and biochemical changes. Elucidating its molecular mechanisms is crucial for diagnosing and developing effective treatments. NLR Family CARD Domain Containing 4 (NLRC4) encodes the key components of inflammasomes that function as pattern recognition receptors. The purpose of this study was to investigate the potential of NLRC4 methylation as a biomarker for KD.

Methods: In this study, pyrosequencing was utilized to analyze NLRC4 promoter methylation in blood samples from 44 children with initial complete KD and 51 matched healthy controls. Methylation at five CpG sites within the NLRC4 promoter region was evaluated.

Results: Compared to controls, NLRC4 methylation significantly decreased in KD patients (CpG1: p = 2.93E-06; CpG2: p = 2.35E-05; CpG3: p = 6.46E-06; CpG4: p = 2.47E-06; CpG5: p = 1.26E-05; average methylation: p = 5.42E-06). These changes were significantly reversed after intravenous immunoglobulin (IVIG) treatment. ROC curve analysis demonstrated remarkable diagnostic capability of mean NLRC4 gene methylation for KD (areas under ROC curve = 0.844, sensitivity = 0.75, p = 9.61E-06, 95% confidence intervals were 0.762-0.926 for mean NLRC4 methylation). In addition, NLRC4 promoter methylation was shown to be significantly negatively correlated with the levels of central granulocyte percentage, age, mean haemoglobin quantity and mean erythrocyte volume. Besides, NLRC4 promoter methylation was positively correlated with lymphocyte percentage, lymphocyte absolute value.

Conclusions: Our work revealed the role of peripheral NLRC4 hypomethylation in KD pathogenesis and IVIG treatment response, could potentially serve as a treatment monitoring biomarker, although its precise functions remain to be elucidated.

References

Shulman S, Rowley A . Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015; 11(8):475-82. DOI: 10.1038/nrrheum.2015.54. View

Eeckhout E, Asaoka T, Van Gorp H, Demon D, Girard-Guyonvarch C, Andries V . The autoinflammation-associated NLRC4 mutation increases microbiota-independent IL-18 production but does not recapitulate human autoinflammatory symptoms in mice. Front Immunol. 2023; 14:1272639. PMC: 10713841. DOI: 10.3389/fimmu.2023.1272639. View

Piotrowska M, Gliwinski M, Trzonkowski P, Iwaszkiewicz-Grzes D . Regulatory T Cells-Related Genes Are under DNA Methylation Influence. Int J Mol Sci. 2021; 22(13). PMC: 8267835. DOI: 10.3390/ijms22137144. View

Matico R, Yu X, Miller R, Somani S, Ricketts M, Kumar N . Structural basis of the human NAIP/NLRC4 inflammasome assembly and pathogen sensing. Nat Struct Mol Biol. 2024; 31(1):82-91. PMC: 10803261. DOI: 10.1038/s41594-023-01143-z. View

Ikeda K, Yamaguchi K, Tanaka T, Mizuno Y, Hijikata A, Ohara O . Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol. 2009; 160(2):246-55. PMC: 2857948. DOI: 10.1111/j.1365-2249.2009.04073.x. View

Guo H, Callaway J, Ting J . Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015; 21(7):677-87. PMC: 4519035. DOI: 10.1038/nm.3893. View

Kuo H, Hsu Y, Wu M, Woon P, Wong H, Tsai L . FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease. Mediators Inflamm. 2015; 2015:564625. PMC: 4451985. DOI: 10.1155/2015/564625. View

Raghawan A, Ramaswamy R, Radha V, Swarup G . HSC70 regulates cold-induced caspase-1 hyperactivation by an autoinflammation-causing mutant of cytoplasmic immune receptor NLRC4. Proc Natl Acad Sci U S A. 2019; 116(43):21694-21703. PMC: 6815140. DOI: 10.1073/pnas.1905261116. View

Amaral M, Cardoso F, de Farias I, de Souza R, Matteucci K, Torrecilhas A . NAIP/NLRC4 inflammasome participates in macrophage responses to by a mechanism that relies on cathepsin-dependent caspase-1 cleavage. Front Immunol. 2023; 14:1282856. PMC: 10731265. DOI: 10.3389/fimmu.2023.1282856. View

10.

Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M . Kawasaki disease in families. Pediatrics. 1989; 84(4):666-9. View

11.

Shahi A, Afzali S, Firoozi Z, Mohaghegh P, Moravej A, Hosseinipour A . Potential roles of NLRP3 inflammasome in the pathogenesis of Kawasaki disease. J Cell Physiol. 2023; 238(3):513-532. DOI: 10.1002/jcp.30948. View

12.

Kuo H, Li S, Huang L, Huang Y . Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease. Oncotarget. 2017; 8(37):60875-60891. PMC: 5617391. DOI: 10.18632/oncotarget.19650. View

13.

Chang L, Lo M, Li S, Yang M, Hsieh K, Kuo H . The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease. Oncotarget. 2016; 8(2):2044-2052. PMC: 5356778. DOI: 10.18632/oncotarget.13489. View

14.

Shao S, Sun Z, Chu M, Chen J, Cao T, Swindell W . Formylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activation. Br J Dermatol. 2023; 190(4):536-548. DOI: 10.1093/bjd/ljad455. View

15.

Sultan Y, Kazatchkine M, Maisonneuve P, Nydegger U . Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984; 2(8406):765-8. DOI: 10.1016/s0140-6736(84)90701-3. View

16.

Li T, Ortiz-Fernandez L, Andres-Leon E, Ciudad L, Javierre B, Lopez-Isac E . Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci. Genome Med. 2020; 12(1):81. PMC: 7519528. DOI: 10.1186/s13073-020-00779-6. View

17.

Huang Y, Li S, Huang L, Chen P, Lin Y, Lin C . Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease. Oncotarget. 2017; 8(7):11249-11258. PMC: 5355262. DOI: 10.18632/oncotarget.14497. View

18.

Chidambaram A, Ramamoorthy J, Anantharaj A . Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children With Kawasaki Disease. Indian Pediatr. 2023; 60(3):207-211. View

19.

Huang Y, Lo M, Cai X, Kuo H . Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease. Oncotarget. 2018; 9(27):18939-18948. PMC: 5922368. DOI: 10.18632/oncotarget.24851. View

20.

Javaid N, Hirai H, Che F, Choi S . Molecular Basis for the Activation of Human Innate Immune Response by the Flagellin Derived from Plant-Pathogenic Bacterium, . Int J Mol Sci. 2021; 22(13). PMC: 8268093. DOI: 10.3390/ijms22136920. View